Drug Topics
MAY 18, 2025
Researchers conducted a clinical review detailing the intersection of dermatology and suicide, explaining why skin conditions lead to increased risk of poor mental health.
Pharmacy Times
MAY 18, 2025
Naxitamab-gqgk has been added as a Category 2A recommendation in the updated National Comprehensive Cancer Network (NCCN) guidelines for high-risk neuroblastoma, reflecting growing consensus on its role in treating relapsed or refractory disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
MAY 18, 2025
Imagine youre trying to reach a specialist in a bustling hospitalyour message is a whisper in a sea of noise. How do you get through? In the complex world of healthcare, pharmaceutical marketing strategies must evolve to genuinely connect with healthcare professionals (HCPs). No longer effective are blanket tactics or generic messaging. Instead, today’s successful marketers are leveraging personalized, data-driven, and omnichannel approaches that meet HCPs where they are.
The FDA Law Blog
MAY 18, 2025
By Charles D. Snow Operation Stork Speed is a go! On March 18, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) launched a significant initiative called Operation Stork Speed to bolster the availability and safety of infant formula in the United States (see our previous blog post here ). The March announcement outlined six key actions underlying Operation Stork Speed, including the launch of the first comprehensive review of infant formula
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Marketing Network
MAY 18, 2025
Can a flashy website really move the needle for an oncology brand? Is social media too risky for pharma compliance? These questions reflect some of the biggest myths in digital marketing in pharma , an area that continues to evolve at warp speed yet remains tethered by legacy thinking. Many marketers in the pharmaceutical industry struggle to balance innovation with regulation, often falling into traps set by outdated beliefs.
pharmaphorum
MAY 18, 2025
The FDA has approved the first blood test for Alzheimer's disease based on a blood test from Fujirebio in a step forward for early diagnosis
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
MAY 18, 2025
FDA finally okays Novavax's COVID-19 jab, with restrictions Phil.
STAT
MAY 18, 2025
WASHINGTON — Former President Joe Biden has been diagnosed with prostate cancer, his office said Sunday. Biden was seen last week by doctors after urinary symptoms and a prostate nodule was found. He was diagnosed with prostate cancer on Friday, with the cancer cells having spread to the bone.
Med Ed 101
MAY 18, 2025
JK is a 77-year-old male who reports a 1-week history of intermittent dizziness and episodes of loss of balance, particularly when walking around. He denies any recent falls, headaches, visual changes, or chest pain. He describes the sensation as “lightheaded” and like the room spins a little. Past Medical History: Current Medications: What should be […] The post Loss of Balance Case Study appeared first on Med Ed 101.
Expert insights. Personalized for you.
492 
Let's personalize your content